Latest Breaking News On - Singapore health sciences authority - Page 14 : comparemela.com

NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE

NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New zealandSouth east asiaRichard quekCarlo montagnerGi cancer institute australiaEuropean society for medical oncology virtual meetingCorporate affairs emma powerDeciphera pharmaceuticalsSingapore health sciences authorityHealth sciences authoritySpecialised therapeutics asiaBlinded independent central reviewResponse evaluation criteriaSolid tumorsManager communicationsSpecialised therapeutics

NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE

/PRNewswire/ Independent biopharmaceutical company Specialised Therapeutics Asia (ST) is pleased to announce that a new therapy to treat rare.

New zealandRichard quekSouth east asiaCarlo montagnerHealth sciences authorityEuropean society for medical oncology virtual meetingSingapore health sciences authorityDeciphera pharmaceuticalsCorporate affairs emma powerGi cancer institute australiaSpecialised therapeutics asiaExecutive officer carlo montagnerManager communicationsSpecialised therapeuticsResponse evaluation criteriaSolid tumors

Singapore HSA fines 13 people for selling e-vapourisers illegally

Singapore’s Health Sciences Authority (HSA) has prosecuted and slapped SGD 102,000 worth of fines on 13 persons for selling electronic vapourisers (e-vapourisers) and related components.

Jun kaiGuo wei arronSingapore health sciences authorityCheckpoints authorityHealth sciences authorityWoodlands checkpoint

Regulatory Agencies Medical Packaging Pros Should Know

Bookmark this list of US and international regulatory agencies for packaging of medical devices and combination products.

United kingdomJapan pharmaceuticalsKorean ministry of foodSingapore health sciences authorityRegulatory agencyAustralia therapeutic goods administrationDevices agencyDrug administrationDrug administration centerEuropean union medical device regulationsRadiological healthBiologics evaluationDrug evaluationTherapeutic goods administrationMedical device regulationsMedical devices

Cold Laser Therapy Market are expected to rise at a CAGR of 4 4% and be worth around US$ 180 8 milli

The global Cold Laser Therapy Market is anticipated to be worth US$ 117.1 million by the end of 2023 and to grow at a CAGR of 4.4% to be worth US$ 180.8 million by the end of 2033. In 2023, continuous laser devices are predicted to have the largest market share worldwide, with an estimated share of about 55.6%, acco.

United statesSouth koreaNew yorkGlobal incSingapore health sciences authorityErchonia corporationCold laser therapy marketDrug administrationTheralase incApira science incGreater new york chamberSurgical centersMarket insights incPhotomedicine ltdBiolight technologiesFuture market